3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
6
Rectal Neoplasms
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
5
Leukemia
5
Colonic Neoplasms
5
Multiple Myeloma
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Immunoblastic Lymphadenopathy
4
Colorectal Neoplasms
4
Burkitt Lymphoma
4
Waldenstrom Macroglobulinemia
3
Stomach Neoplasms
3
Sezary Syndrome
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Esophageal Neoplasms
3
Congenital Abnormalities
3
Interventions
Temozolomide
53
Bevacizumab
33
Radiotherapy
27
Radiation
12
Erlotinib Hydrochloride
12
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
8
Irinotecan
6
Vorinostat
5
Sorafenib
5
Sirolimus
5
temsirolimus
4
Magnetic Resonance Spectroscopy
4
Immunoglobulin G
4
Disulfides
4
Carmustine
4
veliparib
3
plerixafor
3
carmustine, poliferprosan 20 drug combination
3
Radiosurgery
3
Everolimus
3
Dasatinib
3
Bortezomib
3
vandetanib
2
tandutinib
2
sargramostim
2
poly ICLC
2
pembrolizumab
2
pazopanib
2
ferric pyrophosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gliosarcoma
×
Gene Expression Profiling
×
Clear all
No trials found.